This course has concluded on November 10, 2019

CE InformationCourse Outline

    CME4HD

    Session Dates

    SessionStartEnd
    Saturday, November 10, 2018November 10, 2018 8:30amNovember 10, 2018 5:30pm

    Faculty

    Daniel Claassen, MD
    Associate Professor of Neurology
    Director, Huntington's Disease Center of Excellence
    Vanderbilt University Medical Center
    Nashville, Tennessee

    Mary C. Edmondson, MD
    Medical Director HD Reach
    Black Mountain Neuro-Medical Treatment Center
    Black Mountain, North Carolina

    Erin Furr-Stimming, MD
    Associate Professor, Neurology
    Director, HD Clinic, HDSA Center of Excellence
    The University of Texas Health Science Center at Houston
    McGovern Medical School
    Houston, Texas

    Jaime Hatcher-Martin, MD
    Assistant Professor, Neurology
    Jean and Paul Amos Parkinson's Disease & Movement Disorders Program
    Emory University School of Medicine
    Atlanta, Georgia

    Christine Hunter, BSN, RN, CCRC
    Instructor, Neurology
    Research Nurse Manager
    Parkinson's Disease Center and Movement Disorders Clinic
    Baylor College of Medicine
    Houston, Texas

    Martha Nance, MD
    Hennepin County Medical Center
    HD Center of Excellence
    Struthers Parkinson’s Center
    Minneapolis, Minnesota

    Victor Sung, MD
    Director, UAB/HDSA HD Center of Excellence
    Associate Professor, Department of Neurology, Division of Movement Disorders
    UAB Medicine
    Birmingham, Alabama

    Vicki Wheelock, MD
    Health Sciences Clinical Professor
    UC Davis Department of Neurology
    Director, HDSA Center of Excellence at UC Davis
    Sacramento, California

    Intended Learners

    This activity is designed for healthcare professionals, including social workers, nurses, and neurologists, who provide care to patients with Huntington’s disease.

    Learning Objectives

    After completing this activity, participants should be able to:

    • Core features of Huntington disease with an up-to-date understanding of the diagnosis, staging, and typical symptoms of HD, as well as approaches to treatment;
    • Ethical dilemmas in genetic testing and current options in reproductive technologies for HD patients and families;
    • Strategies for behavioral, psychiatric/cognitive, and neurological management of the disease, as well as symptom identification and care options;
    • Translation of complex clinical information to patients and family, the development of therapeutic relationships, and possess an understanding of available support resources;
    • And the role of ancillary services such as rehabilitation therapies, genetics, psychology, and social services, in the management of HD

    Activity Overview

    CME4HD will occur on Saturday November 10, 2018 at the Hotel ZaZa, Houston, Texas.  A question-and-answer session with the faculty will follow each presentation. 

    Instructions for Receiving Documentation of Credit

    To be eligible for documentation of credit, participants must complete the online evaluation form at www.naccme.com. All individuals who participate in the conference and submit the completed evaluation form online may immediately print their documentation of credit.

    For questions regarding this educational activity, please call 609-371-1137.

     

    Accreditation

     

    In support of improving patient care, this activity has been planned and implemented by North   American Center for Continuing Medical Education (NACCME) and Huntington Study Group.  NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    CME
    NACCME designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™.

    Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Physician Assistants

    NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 4.50 AAPA Category 1 credit(s).

    PAs should only claim credit commensurate with the extent of their participation.

    CNE
    This continuing nursing education activity awards 4.5 contact hours.

    Provider approved by the California Board of Registered Nursing, Provider #13255 for 4.5 contact hours.

    Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

    Clinical Reviewer

    Independent Clinical Reviewer: Jee Bang, MD, Assistant Professor of Neurology, Johns Hopkins University School of Medicine, Division of Movement Disorders, Clinical Director, Johns Hopkins Huntington Disease Center, Baltimore, Maryland

    Planning Committee

    The planning committee comprises Jee Bang, MD,  Daniel Claassen, MD, Mary C. Edondson, MD, Erin Furr-Stimming, MD, Jaime Hatcher-Martin, MD, Christine Hunter, BSN, RN, CCRC, Nartha Nance, MD, Susie Seaman, NP, Victor Sung, MD, Vicki L. Wheelock, MD; Jennifer Browne, Donna Brophy, Horacio Rodriguez, Mary Johnson, Mike Kearney,  Randy Robbin, and Susan Yarborough NACCME; Kevin Gregory, and Anne Van Dusen Huntington Study Group.

    Financial Disclosure and Conflicts of Interest

    According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

    All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

    The faculty has reported the following:

    Dr. Claassen:  Consulting - Acadia, Adamas, Vertical Pharmaceuticals; Consulting/Research Support - Lundbeck; Educational activities, Consulting, Research Support -  Teva Neuroscience; Research Support - AbbVie, Biogen, BMS, Eli Lilly, Vaccinex, Wave Life Science

    Dr. Edmondson:  Clinical Advisor/Committee Member - Wave Life Sciences; Employment contract for anesthesia services (spouse/partner) - Vidant Healthcare; Volunteer - Huntington Study Group

    Dr. Furr-Stimming:  Advisory network - Adamas; Research funding/Enroll HD - CHDI; Research funding/SIGNAL - Vaccinex; Speaking - Medscape (grant from Teva)

    Dr. Nance:  Consultant - Roche; Grant funding - Teva 

    Dr. Sung: Consultant - Acadia Pharmaceuticals 

    Dr. Bang:  Has disclosed no relevant financial relationships with any commercial interests.

    Dr. Hatcher-Martin: Has disclosed no relevant financial relationships with any commercial interests. 

    Ms. Hunter: Has disclosed no relevant financial relationships with any commercial interests. 

    Dr. Wheelock:  Has disclosed no relevant financial relationships with any commercial interests.

    NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

    The faculty has disclosed that the off-label/unapproved use of all psychotropic medication for the use of depression, anxiety, insomnia, irritability, perseveration, and other psychiatric symptoms of HD and for the behavioral management of HD will be discussed in the presentation. 

    ADA Statement

    Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Huntington Study Group prior to the live event at jbrowne@naccme.com.

     

    Privacy Policy

    NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

    NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

    Copyright © 2018 by North American Center for Continuing Medical Education, LLC (NACCME). All rights reserved. Opinions expressed by presenters are their own and not necessarily those of their institution or NACCME.

    Provided by North American Center for Continuing Medical Education, LLC, An HMP Communications Holdings Company

    Grant Support

    This activity has been supported through an independent educational grant from Teva Pharmaceuticals.